Results 81 to 90 of about 784,189 (409)

Transcatheter Management of Severe Paravalvular Leak in the Inferior Vena Cava Prosthesis of the TricValve Bicaval Valve System

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT We present a 74‐year‐old female with a history of mechanical aortic and mitral valve implantation and non‐Hodgkin lymphoma. She presented with right sided heart failure due to severe functional tricuspid regurgitation and was treated with transcatheter TricValve bicaval system implantation.
Marcel A. Beijk, Robbert J. De Winter, Berto J. Bouma   +2 more
wiley   +1 more source

Relationship between incidentally detected calcification of the mitral valve on 64-row multidetector computed tomography and mitral valve disease on echocardiography

International Journal of General Medicine, 2012
Mehrnoush Toufan,1 Reza Javadrashid,2 Neda Paak,2 Morteza Gojazadeh,3 Majid Khalili41Cardiovascular Research Center, 2Department of Radiology, 3Medical Philosophy and History Research Center, Tabriz University of Medical Sciences, Tabriz, Iran ...
Toufan M, Javadrashid R, Paak N, Gojazadeh M, Khalili M   +4 more
doaj  

Intracardiac Calcification - An Interesting Chest X-ray Report. [PDF]

, 2013
We report a case of chest X-ray finding of mitral annular calcification. Mitral annular calcification is a degenerative process involving the fibrous annulus of the mitral valve.
Anupama, N, Basavaraj, S, Harsha, DS, Pradeepa, N, Sharma, VM, Simon, RA   +5 more
core  

Outcomes of Fluoroscopy‐Based Asymmetric Underexpansion With the Self‐Expanding ACURATE Neo and Neo2 Valve

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Asymmetric underexpansion of transcatheter heart valves (THVs), as observed on fluoroscopy, may influence prosthesis function or long‐term durability of transcatheter aortic valve implantation (TAVI). Aims This study aimed to evaluate the effect of stent frame asymmetry on hemodynamic performance and clinical outcomes in ACURATE neo
Daisuke Sato, Noriaki Moriyama, Hirokazu Miyashita, Yoichi Sugiyama, Tommi Vähäsilta, Teemu Laakso, Sebastian Dahlbacka, Tiina Vainikka, Juho Viikilä, Mika Laine, Mikko Jalanko   +10 more
wiley   +1 more source

3D echocardiography in mitral valve prolapse

Frontiers in Cardiovascular Medicine, 2023
Mitral valve prolapse (MVP) is the leading cause of mitral valve surgery. Echocardiography is the principal imaging modality used to diagnose MVP, assess the mitral valve morphology and mitral annulus dynamics, and quantify mitral regurgitation.
Valentina Mantegazza, Valentina Mantegazza, Paola Gripari, Gloria Tamborini, Manuela Muratori, Laura Fusini, Laura Fusini, Sarah Ghulam Ali, Anna Garlaschè, Mauro Pepi   +9 more
doaj   +1 more source

Noncoronary Sinus Pivot Implantation (NCPI) Strategy for Transcatheter Aortic Valve Replacement With Self‐Expanding Valve in Pure Native Aortic Regurgitation: A Multicenter, Registry Study From the CCA Database‐NTCVR

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Transcatheter aortic valve replacement (TAVR) for pure native aortic regurgitation (PNAR) remains challenging. While the noncoronary sinus pivot implantation (NCPI) strategy showed promise with VitaFlow valve, its efficacy with other valves needs validation. Aims This study aims to evaluate the real‐world efficacy of the TaurusElite
Feng Xia, XinJing Chen, ZiLong Weng, Xin Pan, JinJun Liu, Hao Zhou, LianPin Wu, YanSong Guo, LongYan Zhang, WenZhi Pan, DaXin Zhou, JunBo Ge   +11 more
wiley   +1 more source

Heart valve operations associated with reduced risk of death from mitral valve disease but other operations associated with increased risk of death: a national population-based case–control study

Journal of Cardiothoracic Surgery, 2019
Background Mitral valve disease is the most common heart valve disease worldwide. Heart valve operation is the predominant treatment strategy for heart valve disease.
Ruo-Ling Li, Ci-Wen Luo, Yung-Chyuan Ho, Shiuan-Shinn Lee, Yu-Hsiang Kuan   +4 more
doaj   +1 more source

Mitral valve interventions in heart failure

ESC Heart Failure, 2018
Secondary mitral regurgitation (MR) results from left ventricular dilatation and dysfunction. Quantification of secondary MR is challenging because of the underlying myocardial disease.
D. Lavall, A. Hagendorff, S. Schirmer, M. Böhm, M. Borger, U. Laufs   +5 more
semanticscholar   +1 more source

Long‐Term Survival After Post‐Myocardial Infarction Ventricular Septal Defect (VSD) Closure, Multiple Percutaneous Coronary Interventions and Edge‐to‐Edge Repair

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT This reports a case of a female aged 65 who presented in cardiogenic shock secondary to an inferior ST‐elevation myocardial infarction and was diagnosed with a post‐infarction ventricular septal defect (VSD) and was also found to have severe mitral valve regurgitation. She was not surgically operable, so underwent percutaneous VSD repair. Over
Heidi Turner, Mandie Townsend, Julian Strange, Mark Turner   +3 more
wiley   +1 more source

Emergency transapical mitral valve-in-valve implantation for bioprosthesis failure: transapical implantation of an Edwards Sapien-XT in a dysfunctional mitral bioprosthesis in a critical patient

Journal of Cardiothoracic Surgery, 2017
Background Valve-in-Valve (VIV) Transcatheter Aortic Valve Replacement (TAVR) is now the treatment of choice in high-surgical-risk patients with failing aortic bioprosthesis. Although less performed, VIV-Transcatheter Mitral Valve Replacement (TMVR) is a
Marco Zanobini, Sabrina Manganiello, Giorgia Bonalumi, Raoul Biondi, Marco Russo, Massimo Mapelli, Francesco Alamanni, Matteo Saccocci   +7 more
doaj   +1 more source